Sulprex™ HFA Inhaler

Salbutamol + Ipratropium Bromide
Anticholinergic + Beta-2 stimulant (Antiasthma)

Indication:

Sulprex^TM Inhalation Aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) & asthma on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.

Dosage & Administration:

The dose of Sulprex^TM Inhalation Aerosol is two inhalations four times a day. Patients may take additional inhalations as required; however, the total number of Inhalations should not exceed 12 in 24 hours.

Preparation:

Sulprex^TMInhaler: Each puff delivers 20mcg of Ipratropium Bromide and 100mcg of Salbutamol, 200puffs